Joshua Hayden - When Good Biomarkers Go Bad: Effectively Utilizing Procalcitonin PCT for Sepsis Mana

Watch this webinar on LabRoots at: http://www.labroots.com/webinar/biomarkers-bad-effectively-utilizing-procalcitonin-pct-sepsis-management-demonstrate-value-l

Sepsis, a host-mediated response to a systemic infection, is a leading cause of mortality worldwide (1). Early recognition of infection and initiation of effective therapy is essential to reducing mortality from sepsis; every hour that effective therapy is delayed causes an 8% increase in mortality (2). Sepsis management is now a Centers for Medicare & Medicaid Services (CMS) core measure, and includes a number of required laboratory measurements. One of the most effective biomarkers for sepsis is procalcitonin (PCT) which has demonstrated excellent sensitivity to sepsis. This biomarker puts laboratory leaders in a unique position to greatly impact sepsis protocol by providing a solution that can aid in early identification of systemic bacterial infection, assess mortality risk and guide antimicrobial effectiveness (3). Unfortunately, the utility of PCT has been limited in clinical practice by its availability and turnaround time (TAT). This talk will focus on the role PCT can play in recognizing and managing sepsis as well as the relevant operational features (TAT, availability) and institutional buy-in necessary to achieve maximum utility from this marker of sepsis and the unique opportunity it presents for lab leaders to bring more value to the laboratory.

Видео Joshua Hayden - When Good Biomarkers Go Bad: Effectively Utilizing Procalcitonin PCT for Sepsis Mana канала LabRoots